Search

everythinglearnresearchcommunity

for

Search:↓

Treating PCOS is complex, involving medication like metformin and lifestyle changes, and requires attention to mental health due to high depression and anxiety rates.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

A 13-year-old boy had a rare, stable type of hair loss with little chance of regrowth, but treatment is available for looks.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

Most women with excessive hair growth have a hormonal cause.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Genetics and hormones cause hair loss; finasteride treats it safely.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

A woman with X-linked chronic granulomatous disease developed lupus-like skin lesions, improved with treatment, suggesting a unique skin condition in carriers.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.